2021
DOI: 10.1016/j.colsurfa.2021.126789
|View full text |Cite
|
Sign up to set email alerts
|

Cetyltrimethylammonium bromide promoted dispersing and incorporation of curcumin into silica particles in alkaline ethanol/water mixture

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 31 publications
0
3
0
Order By: Relevance
“…In the case of curcumin encapsulation in micelles from cetyltrimethylammonium bromide, and their subsequent coating with silica [ 31 ], using thermogravimetric analysis it was determined that about 40% of curcumin was packed into silica particles. A higher cytotoxicity of such a form was found as compared to unmodified curcumin [ 32 ].…”
Section: Nanoparticlesmentioning
confidence: 99%
“…In the case of curcumin encapsulation in micelles from cetyltrimethylammonium bromide, and their subsequent coating with silica [ 31 ], using thermogravimetric analysis it was determined that about 40% of curcumin was packed into silica particles. A higher cytotoxicity of such a form was found as compared to unmodified curcumin [ 32 ].…”
Section: Nanoparticlesmentioning
confidence: 99%
“…Because of its flavoring properties, CUR is used as a food coloring, and as a traditional medicine in India and China for the treatment and prevention of several diseases, such as neurological, oncological, autoimmune, metabolic, cardiovascular, and diabetes, due to its extraordinary activities [3][4][5]23], which have attracted increasing interest from researchers to CUR [25]. However, the use of CUR in therapeutic applications has been limited due to its poor bioavailability and water solubility [4,26,27]. In fact, CUR belongs to Class IV of the Biopharmaceutics Classification System (BCS), whose solubility is about 7.8 µg mL −1 , which can be improved by various strategies of synthesizing appropriate formulations (e.g., solid lipid nanoparticles, solid dispersion, colloidal drug delivery systems, microemulsions, and multi-component crystals) [24].…”
Section: Preparation Of the Cs-and Cs-cur-based Macrobeadsmentioning
confidence: 99%
“…In fact, CUR belongs to Class IV of the Biopharmaceutics Classification System (BCS), whose solubility is about 7.8 µg mL −1 , which can be improved by various strategies of synthesizing appropriate formulations (e.g., solid lipid nanoparticles, solid dispersion, colloidal drug delivery systems, microemulsions, and multi-component crystals) [24]. Encapsulation of CUR within materials, such as CS-based materials, is a strategic approach to improve its dispersibility in aqueous media, chemical stability, controlled release ability, bioactivity, and, thus, use in therapeutic treatment [4,26,28,29]. By way of example, Asif et al [30] reported the synthesis, characterization, and in vitro study of CUR-loaded CS-nanoparticles to enhance the solubility and bioavailability of CUR and to determine the anti-inflammatory and anti-arthritic activities.…”
Section: Preparation Of the Cs-and Cs-cur-based Macrobeadsmentioning
confidence: 99%